share_log

Barrington Research Upgrades Anika Therapeutics to Outperform, Announces $24 Price Target

Benzinga ·  Aug 14, 2023 08:46

Barrington Research analyst Michael Petusky upgrades Anika Therapeutics (NASDAQ:ANIK) from Market Perform to Outperform and announces $24 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment